Thrombopoietin Promotes Adhesion of Primitive Human Hemopoietic Cells to Fibronectin and Vascular Cell Adhesion Molecule-1: Role of Activation of Very Late Antigen (VLA)-4 and VLA-5

Journal of Immunology

Volumn 159, Issue 4, 1997, Pages 1961-1969

  Cui, Li ^a,b   Ramsfjell, Veslemøy ^a,b   Borge, Ole J ^a,b   Veiby, Ole P ^a,b   Lok, Si ^c   Jacobsen, Sten E W ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Hippie Cancer Research Center   (United States)

^c ZYMOGENETICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; CD34 ANTIGEN; CD38 ANTIGEN; CD38 PROTEIN, HUMAN; CD38 PROTEIN, MOUSE; DIFFERENTIATION ANTIGEN; FIBRONECTIN; FIBRONECTIN RECEPTOR; GLYCOSIDASE; HOMING RECEPTOR; INTEGRIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; THROMBOPOIETIN; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ANIMAL; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL CULTURE; DRUG EFFECT; HEMATOPOIETIC STEM CELL; HUMAN; MOUSE; PHYSIOLOGY; SECOND MESSENGER;

ADP-RIBOSYL CYCLASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; BONE MARROW CELLS; CELL ADHESION; FIBRONECTINS; HEMATOPOIETIC STEM CELLS; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; MEMBRANE GLYCOPROTEINS; MICE; N-GLYCOSYL HYDROLASES; RECEPTORS, FIBRONECTIN; RECEPTORS, LYMPHOCYTE HOMING; SECOND MESSENGER SYSTEMS; THROMBOPOIETIN; TUMOR CELLS, CULTURED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031571328     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Spangrude, G. J., L. Smith, N. Uchida, K. Ikuta, S. Heimfeld, J. Friedman, and I. L. Weissman. 1991. Mouse hematopoietic stem cells. Blood 78:1395.
2. Moore, M. A. S. 1991. Clinical implications of positive and negative hematopoictic stem cell regulators. Blood 78:1.
3. Metcalf, D. 1993. Hematopoietic regulators: redundancy or subtlety. Blood 82:1515.
4. Ogawa, M. 1993. Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844.
5. Simmons, P. J., A. Xannettino, S. Gronthos, and D. Leavesley. 1994. Potential adhesion mechanisms Cor localisation of hemopoietic progenitors to bone marrow stroma. Leuk. Lymphoma 12:353.
6. Dexter, T. M., T. D. Allen, and L. G. Lajtha. 1977. Conditions controlling the proliferation of hematopoietic cells in vitro. J. Cell. Physiol. 91:335.
7. Yoder, M. C., and D. A. Williams. 1995 Matrix molecule interactions with hematopoietic stem cells. Exp. Hematol. 23:961.
8. Greenberger, J. S. 1991. The hematopoietic environment. Crit. Rev. Oncol. Hematol. 11:65.
9. Verfaillie, C., R. Hurley, R. Bhatia, and J. McCarthy. 1994. Role of bone marrow matrix in normal and abnormal hematopoiesis. Crit. Rev. Oncol. Hematol. 16:201.
10. + hematopoietic cells. Exp. Hematol. 20:24.
11. Miyake, K., I. L. Weissman, J. S. Greenberger, and P. W. Kincade. 1991. Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J. Exp. Med. 173:599.
12. Williams, D. A., M. Rios, C. Stephens, and V. P. Patel. 1991. Fibronectin and VLA-4 in hematopoietic stem cell-microenvironment interactions. Nature 352:438.
13. Yanai, N., C. Sekine, H. Yagita, and M. Obinata. 1996. Role for integrin very late activation antigen-4 in stroma-dependent erythropoiesis. Blood 83:2844.
14. Simmons, P. J., B. Masinovsky, B. M. Longenecker, R. Berenson, B. Torok-Storb, and W. M. Gallatin. 1992. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 80:388.
15. + cells to fibronectin in an activation-dependent way. Blood 81:344.
16. hi stem cells to bone marrow stroma. J. Clin. Invest. 90:358.
17. Levesque, J. P., D. I. Leavesley, S. Niutta, M. Vadas, and P. J. Simmons. 1995. Cytokine increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J. Exp. Med. 181:1805.
18. 4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc. Natl. Acad. Sci. USA 92:9647.
19. 1 integrins expressed on hematopoietic cell lines. Blood 85:159.
20. Dittel, B. N., and T. W. LeBien. 1995. Reduced expression of vascular cell adhesion molecule-1 on bone marrow stromal cells isolated from marrow transplant recipients correlates with a reduced capacity to support human B lymphopoiesis in vitro. Blood 86:2833.
21. Weinstein, R., M. A. Riordan, K. Wenc, S. Kreczko, M. Zhou, and N. Dainiak. 1989. Dual role of fibronectin in hematopoietic differentiation. Blond 73:111.
22. Hurley, R. W., J. B. McCarthy, and C. M. Verfaillie. 1995. Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J. Clin. Invest. 96:511.
23. 1 integrin-mediated adhesion to fibronectin decreases proliferation of chronic myelogenous leukemia progenitors and K562 cells. Blood 87:2450.
24. Moritz, T., V. P. Patel, and D. A. Williams. 1994. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J. Clin. Invest. 93:1451.
25. Sugahara, H., Y. Kanakura, T. Furitsu, K. Ishihara, K. Oritani, H. Ikeda, H. Kitayama, J. Ishikawa, K. Hashimoto, Y. Kanayama, and Y. Matsuzawa. 1994. Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5. J. Exp. Med. 179:1757.
26. Hardy, C. L., and J. J. Minguell. 1995. Modulation of the adhesion of hemopoietic progenitor cells to the RGD site of fibronectin by interleukin 3. J. Cell. Physiol. 164:315.
27. Kinashi, T., and T. A. Springer. 1994. Steel factor and c-kit regulate cell-matrix adhesion. Blood 83:1033.
28. + hemopoietic progenitors. Blood 88:1168.
29. Kaushansky, K. 1995. Thrombopoietin: the primary regulator of platelet production. Blood 86:419.
30. Lok, S., K. Kaushansky, R. D. Holly, J. L. Kuijper, C. E. Lofton-Day, P. J. Oort, F. J. Grant, M. D. Heipel, S. K. Burkhead, and J. M. Kramer. 1994. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565.
31. de Sauvage, F. J., P. E. Hass, S. D. Spencer, B. E. Malloy, A. L. Gurney, S. A. Spencer, W. C. Darbonne, W. J. Henzel, S. C. Wong, and W. J. Kuang. 1994. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369:533.
32. Bartley, T. D., J. Bogenberger, P. Hunt, Y. S. Li, H. S. Lu, F. Martin, M. S. Chang, B. Samal, J. L. Nichol, and S. Swift. 1994. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117.
33. Wendling, F., E. Maraskovsky, N. Debili, C. Florindo, M. Teepe, M. Titeux, N. Methia, J. Breton-Gorius, D. Cosman, and W. Vainchenker. 1994. c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369:571.
34. Sohma, Y., H. Akahori, N. Seki, T. Hori, K. Ogami, T. Kato, Y. Shimada, K. Kawamura, and H. Miyazaki. 1994. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett. 353:57.
35. Kuter, D. J., D. L. Beeler, and R. D. Rosenberg. 1994. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc. Natl. Acad. Sci. USA 91:11104.
36. Gurney, A. L., K. Carver-Moore, F. J. de Sauvage, and M. W. Moore. 1994. Thrombocytopenia in c-mpl-deficient mice. Science 265:1445.
37. Warren, S. A., A. W. Roberts, N. A. Nicola, R. Li, and D. Melcalf. 1996. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood 87:2162.
38. Broudy, V. C., N. L. Lin, and K. Kaushansky. 1995. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 85:1719.
39. Debili, N., F. Wendling, A. Katz, J. Guichard, J. Breton-Gorius, P. Hunt, and W. Vainchenker. 1995. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 86:2516.
40. Banu, N., J. F. Wang, B. Deng, J. E. Groopman, and H. Avraham. 1995. Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand. Blood 86:1331.
41. Kobayashi, M., J. H. Laver, T. Kato, H. Miyazaki, and M. Ogawa. 1995. Recombinant human thrombopoietin (mpl ligand) enhances proliferation of erythroid progenitors. Blood 86:2494.
42. Kaushansky, K., V. C. Broudy, A. Grossmann, J. Humes, N. Lin, H. P. Ren, M. C. Bailey, T. Papayannopoulou, J. W. Forstrom, and K. H. Sprugel. 1995. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J. Clin. Invest. 96:1683.
43. Zeigler, F. C., F. de Sauvage, H. R. Widmer, G. A. Keller, C. Donahue, R. D. Schreiber, B. Malloy, P. Hass, D. Eaton, and W. Matthews. 1994 In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 84:4045.
44. Methia, N., F. Louache, W. Vainchenker, and F. Wendling. 1993. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 82:1395.
45. Berardi, A. C., A. Wang, J. D. Levine, P. Lopez, and D. T. Scadden. 1995. Functional isolation and characterization of human hematopoietic stem cells. Science 267:104.
46. Huang, Y., H. Shinzawa, H. Togashi, T. Takahashi, T. Kuzumaki, K. Otsu, and K. Ishikawa. 1995. Interleukin-6 down-regulates expressions of the aldolase B and albumin genes through a pathway involving the activation of tyrosine kinase. Arch. Biochem. Biophys. 320:203.
47. + T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J. Immunol. 145:59.
48. Rodriguez, R. M., C. Pitzalis, G. H. Kingsley, E. Henderson, M. J. Humphries, and G. S. Panayi. 1992. T lymphocyte adhesion to fibronectin (Fn): a possible mechanism for T cell accumulation in the rheumatoid joint. Clin. Exp. Immunol. 89:439.
49. 1 integrin receptor. J. Biol. Chem. 266:24367.
50. Avanzi, G. C., P. Lista, B. Giovinazzo, R. Miniero, G. Saglio, G. Benetton, R. Coda, G. Cattoretti, and L. Pegoraro. 1988. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Br. J. Hematol. 69:359.
51. Hendrie, P. C., K. Miyazawa, Y. C. Yang, C. D. Langefeld, and H. E. Broxmeyer. 1991. Mast cell growth factor (c-kit ligand) enhances cytokine stimulation of proliferation of the human factor-dependent cell line, Mo7e. Exp. Hematol. 19:1031.
52. + cells. Leukemia 6:845.
53. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, and T. Konno. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26:171.
54. Ritchie, A., S. Vadhan-Raj, and H. E. Broxmeyer. 1996. Thrombopoietin suppresses apoptosis and behaves as a survival factor for the human growth factor-dependent cell line, Mo7e. Stem Cell 14:330.
55. Haystead, T. A. J., A. T. R. Sim, D. Carling, R. C. Honnor, Y. Tsukitani, P. Cohen, and D. G. Hardie. 1989. Effects of the tumor promoter okadaic acid on intracellular protein phosphorylation and metabolism. Nature 337:78.
56. s-C coupling. Mol. Pharmacol. 28:502.
57. Toullec, D., P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, L. Duhamel, D. Charon, and J. Kirilovsky. 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:15771.
58. Platanias, L. C., and O. R. Colamonici. 1992. Interferon a induces rapid tyrosine phosphorylation of the a subunit of its receptor. J. Biol. Chem. 267:24053.
59. Kinashi, T., J. A. Escobedo, L. T. Williams, K. Takatsu, and T. A. Springer. 1995. Receptor tyrosine kinase stimulates cell-matrix adhesion by phosphatidylinositol 3 kinase and phospholipase C-gamma 1 pathways. Blood 86:2086.
60. Kinashi, T., and T. A. Springer. 1995. Regulation of cell-matrix adhesion by receptor tyrosine kinases. Leuk. Lymphoma 18:203.
61. Shimizu, Y., and S. W. Hunt, 3rd. 1996. Regulating integrin-mediated adhesion: one more function for PI 3- kinase? Immunol. Today 17:565.
62. Zauli, G., A. Bassini, M. Vitale, D. Gibellini, C. Celeghini, E. Caramelli, S. Pierpaoli, L. Guidotti, and S. Capitani. 1997. Thrombopoietin enhances the alpha IIb beta 3-dependent adhesion of megakaryocytic cells to fibrinogen or fibronectin through PI 3 kinase. Blood 89:883.
63. Hidaka, H., M. Inagaki, S. Kawamoto, and Y. Sasaki. 1984. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23:5036.
64. Powis, G., R. Bonjouklian, M. M. Berggren, A. Gallegos, R. Abraham, C. Ashendel, L. Zalkow, W. F. Matter, J. Dodge, and G. Grindey. 1994. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3- kinase. Cancer Res. 54:2419.
65. - progenitor cells. Blood 77:1218.
66. Petzer, A. L., D. E. Hogge, P. M. Lansdorp, D. S. Reid, and C. J. Haves. 1996. Self-renewal of primitive human hematopoietic cells (Long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc. Natl. Acad. Sci. USA 93:1470.
67. + bone marrow cells. Blood 84:1473.
68. Civin, C. I., G. Almeida-Porada, M. J. Lee, J. Olweus, L. W. Terstappen, and E. D. Zanjani. 1996. Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. Blood 88:4102.
69. Larochelle, A., J. Vormoor, H. Hanenberg, J. C. Wang, M. Bhatia, T. Lapidot, T. Moritz, B. Murdoch, X. L. Xiao, I. Kato, D. A. Williams, and J. E. Dick. 1996. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat. Med. 2:1329.
70. Chen, J., L. Herceg-Harjacek, J. E., Groopman, and J. Grabarek. 1995. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. Blood 86:4054.
71. Sitnicka, E., N. Lin, G. V. Priestley, N. Fox, V. C. Broudy, N. S. Wolf, and K. Kaushansky. 1996. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood 87:4998.
72. Ku, H., Y. Yonemura, K. Kaushansky, and M. Ogawa. 1996. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 87:4544.
73. Borge, O. J., V. Ramsfjell, O. P. Veiby, M. J. J. Murphy, S. Lok, and S. E. W. Jacobsen. 1996. Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro. Blood 88:2859.
74. Ramsfjell, V., O. J. Borge, O. P. Veiby, J. Cardier, M. J. Murphy, Jr., S. D. Lyman, S. Lok, and S. E. Jacobsen. 1996. Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3. Blood 88:4481.
75. Kobayashi, M., J. H. Laver, T. Kato, H. Miyazaki, and M. Ogawa. 1996. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood 88:429.
76. -) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of transforming growth factor-β and tumor necrosis factor-α J. Immunol. 158:5169.
77. Carver-Moore, K., H. E. Broxmeyer, S. M. Luoh, S. Cooper, J. Peng, S. A. Burstein, M. W. Moore, and F. J. de Sauvage. 1996. Low levels of erythroid and myeloid progenitors in thrombopoietin- and c-mpl-deficient mice. Blood 88:803.
78. Debili, N., F. Wendung, D. Cosman, M. Titeux, C. Florindo, I. Dusanter-Fourt, K. Schooley, N. Methia, M. Charon, R. Nador, A. Bettaieb, and W. Vainchenker. 1995. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelet. Blood 85:391.
79. - bone marrow cells with multilineage potential in vitro: key role of thrombopoietin. Blood. In press.